• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种受强烈患者偏好影响的用于临床试验研究的新型偏好知情补充试验(PICT)设计。

A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.

作者信息

Ali Samina, Hopkin Gareth, Poonai Naveen, Richer Lawrence, Yaskina Maryna, Heath Anna, Klassen Terry Paul, McCabe Chris

机构信息

Department of Pediatrics, University of Alberta, AB, Edmonton, Canada.

Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Trials. 2021 Mar 12;22(1):206. doi: 10.1186/s13063-021-05164-1.

DOI:10.1186/s13063-021-05164-1
PMID:33712062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953803/
Abstract

BACKGROUND

Patients and their families often have preferences for medical care that relate to wider considerations beyond the clinical effectiveness of the proposed interventions. Traditionally, these preferences have not been adequately considered in research. Research questions where patients and families have strong preferences may not be appropriate for traditional randomized controlled trials (RCTs) due to threats to internal and external validity, as there may be high levels of drop-out and non-adherence or recruitment of a sample that is not representative of the treatment population. Several preference-informed designs have been developed to address problems with traditional RCTs, but these designs have their own limitations and may not be suitable for many research questions where strong preferences and opinions are present.

METHODS

In this paper, we propose a novel and innovative preference-informed complementary trial (PICT) design which addresses key weaknesses with both traditional RCTs and available preference-informed designs. In the PICT design, complementary trials would be operated within a single study, and patients and/or families would be given the opportunity to choose between a trial with all treatment options available and a trial with treatment options that exclude the option which is subject to strong preferences. This approach would allow those with strong preferences to take part in research and would improve external validity through recruiting more representative populations and internal validity. Here we discuss the strengths and limitations of the PICT design and considerations for analysis and present a motivating example for the design based on the use of opioids for pain management for children with musculoskeletal injuries.

CONCLUSIONS

PICTs provide a novel and innovative design for clinical trials with more than two arms, which can address problems with existing preference-informed trial designs and enhance the ability of researchers to reflect shared decision-making in research as well as improving the validity of trials of topics with strong preferences.

摘要

背景

患者及其家属对于医疗护理往往有一些偏好,这些偏好涉及到比所提议干预措施的临床效果更广泛的考量。传统上,这些偏好在研究中并未得到充分考虑。由于对内部和外部效度存在威胁,患者和家属有强烈偏好的研究问题可能不适用于传统的随机对照试验(RCT),因为可能会有高比例的退出和不依从情况,或者招募到的样本不能代表治疗人群。已经开发了几种偏好告知设计来解决传统RCT的问题,但这些设计有其自身的局限性,可能不适用于许多存在强烈偏好和意见的研究问题。

方法

在本文中,我们提出了一种新颖且创新的偏好告知补充试验(PICT)设计,该设计解决了传统RCT和现有偏好告知设计的关键弱点。在PICT设计中,补充试验将在单个研究中进行,患者和/或家属将有机会在一个提供所有治疗选项的试验和一个排除了存在强烈偏好的选项的治疗选项试验之间进行选择。这种方法将使那些有强烈偏好的人能够参与研究,并通过招募更具代表性的人群来提高外部效度和内部效度。在这里,我们讨论了PICT设计的优势和局限性以及分析的考量因素,并基于使用阿片类药物治疗肌肉骨骼损伤儿童的疼痛管理给出了该设计的一个激励性示例。

结论

PICT为具有两个以上臂的临床试验提供了一种新颖且创新的设计,它可以解决现有偏好告知试验设计的问题,并增强研究人员在研究中反映共同决策的能力,同时提高对存在强烈偏好的主题进行试验的效度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/42a69a4073a1/13063_2021_5164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/2e1356a3c60d/13063_2021_5164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/9a896010a065/13063_2021_5164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/42a69a4073a1/13063_2021_5164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/2e1356a3c60d/13063_2021_5164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/9a896010a065/13063_2021_5164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7002/7953803/42a69a4073a1/13063_2021_5164_Fig3_HTML.jpg

相似文献

1
A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.一种受强烈患者偏好影响的用于临床试验研究的新型偏好知情补充试验(PICT)设计。
Trials. 2021 Mar 12;22(1):206. doi: 10.1186/s13063-021-05164-1.
2
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.随机对照试验中参与者和专业人员偏好影响的概念框架与系统评价
Health Technol Assess. 2005 Sep;9(35):1-186, iii-iv. doi: 10.3310/hta9350.
3
Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges.比较不同医疗环境的随机试验:对试验前偏好对参与度影响的探索性综述以及对其他方法学挑战的讨论。
BMC Health Serv Res. 2016 Oct 19;16(1):589. doi: 10.1186/s12913-016-1823-6.
4
Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences.培训招募人员参与随机试验,通过探索患者的治疗偏好来促进招募和知情同意。
Trials. 2014 Aug 13;15:323. doi: 10.1186/1745-6215-15-323.
5
Correction to: A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.对《受强烈患者偏好影响的临床试验研究的新型偏好告知补充试验(PICT)设计》的更正
Trials. 2021 May 20;22(1):353. doi: 10.1186/s13063-021-05312-7.
6
The impact of surgeon and patient treatment preferences in an orthopaedic trauma surgery trial.外科医生和患者治疗偏好对骨科创伤手术试验的影响。
Trials. 2019 Sep 18;20(1):570. doi: 10.1186/s13063-019-3631-x.
7
Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration.探索使用偏好评估方法来为风湿病学临床试验设计提供信息的认知:一项定性研究和 OMERACT 合作。
Semin Arthritis Rheum. 2023 Feb;58:152112. doi: 10.1016/j.semarthrit.2022.152112. Epub 2022 Nov 3.
8
The impact of parent treatment preference and other factors on recruitment: lessons learned from a paediatric epilepsy randomised controlled trial.父母治疗偏好及其他因素对招募的影响:一项儿科癫痫随机对照试验的经验教训。
Trials. 2023 Feb 6;24(1):83. doi: 10.1186/s13063-023-07091-9.
9
Beyond the treatment effect: Evaluating the effects of patient preferences in randomised trials.超越治疗效果:评估随机试验中患者偏好的影响。
Stat Methods Med Res. 2017 Feb;26(1):489-507. doi: 10.1177/0962280214550516. Epub 2016 Jul 11.
10
Understanding preferences regarding consent for pragmatic trials in acute care.了解急性护理中实用临床试验同意书的偏好。
Clin Trials. 2018 Dec;15(6):567-578. doi: 10.1177/1740774518801007. Epub 2018 Oct 3.

引用本文的文献

1
Effectiveness of parent-based electronic health () intervention on physical activity, dietary behaviors, and sleep in preschoolers: A systematic review.基于家长的电子健康干预对学龄前儿童身体活动、饮食行为和睡眠的有效性:一项系统评价。
J Exerc Sci Fit. 2024 Jan;22(1):1-13. doi: 10.1016/j.jesf.2023.10.004. Epub 2023 Oct 28.
2
Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.前列腺癌幸存者中基于偏好的试验与随机对照试验:招募、依从性、损耗及临床结果的比较
Front Oncol. 2022 Dec 12;12:1033229. doi: 10.3389/fonc.2022.1033229. eCollection 2022.
3

本文引用的文献

1
Study protocol for two complementary trials of non-steroidal or opioid analgesia use for children aged 6 to 17 years with musculoskeletal injuries (the No OUCH study).非甾体或阿片类镇痛药用于治疗 6 至 17 岁肌肉骨骼损伤儿童的两项互补试验研究方案(No OUCH 研究)。
BMJ Open. 2020 Jun 21;10(6):e035177. doi: 10.1136/bmjopen-2019-035177.
2
The history and fate of the gold standard.金本位制的历史与命运。
Lancet. 2015 Apr 18;385(9977):1502-3. doi: 10.1016/S0140-6736(15)60742-5.
Correction to: A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.
对《受强烈患者偏好影响的临床试验研究的新型偏好告知补充试验(PICT)设计》的更正
Trials. 2021 May 20;22(1):353. doi: 10.1186/s13063-021-05312-7.